The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Generic Health Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
303 result(s) found, displaying 21 to 30
-
Cancellation by sponsorRequested by Generic Health Pty Ltd
-
Cancellation by sponsorRequested by Generic Health Pty Ltd
-
Cancellation by sponsorRequested by Generic Health Pty Ltd
-
Prescription medicine registrationActive ingredients: Ursodeoxycholic acid.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RISPERIDONE GENERICHEALTH risperidone 1 mg/mL oral liquid solution bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RISPERIDONE LUPIN risperidone 1 mg/mL oral liquid solution bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RISPERIDONE LAPL risperidone 1 mg/mL oral liquid solution bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TERIPARATIDE LAPL teriparatide 250 microgram per mL solution for injection pre-filled cartridge.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TERIPARATIDE LUPIN teriparatide 250 microgram per mL solution for injection pre-filled cartridge.
-
Australian Public Assessment Report (AusPAR)Teriparatide Lupin/ Teriparatide LAPL/ Teriparatide GH (teriparatide) has been approved for the treatment of osteoporosis.